US PTAB IP Litigation
8,722 annotated decisions
Page 238 of 364 · 8,722 total
patent denied · Aug 22, 2024
Google LLC v.--
· IPR2024-01319
Google LLC's attempt to challenge patent 9,679,289 B1 was denied by the PTAB because a prior inter partes review (IPR) of the same patent had already been instituted.
patent denied · Aug 22, 2024
Google LLC v.--
· IPR2024-01318
The PTAB denied Google's attempt to file a second IPR against PROXENSE's patent because the Board had already instituted an earlier review.
patent instituted · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01309
Genius Sports Ltd. successfully convinced the PTAB to institute IPR proceedings against SportsCastr Inc. d/b/a PANDA Interactive regarding live event broadcasting claims. The Board accepted the Petitioner's arguments that the claimed technology is obvious over combinations of prior art references, including Ellis and Spivey. This sets the stage for a full trial on unpatentability grounds.
patent instituted · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01307
Genius Sports Ltd. successfully convinced the PTAB that its claims relating to live event content delivery systems are likely unpatentable over combinations of prior art references (Ellis, Spivey, Herzog). The Board found a reasonable likelihood of success regarding obviousness for multiple claims, leading to institution.
patent instituted · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01308
The PTAB institution decision found reasonable likelihood of unpatentability for Genius Sports Ltd.'s claims against SportsCastr Inc. The Board determined that the combination of prior art references (Ellis, Spivey, Herzog) taught or suggested all limitations of Claim 1 and its dependents based on the preliminary record. This sets a significant hurdle for SportsCastr's patent validity in digital media streaming technology.
patent instituted · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01305
Genius Sports Ltd. successfully convinced the PTAB to institute proceedings against SportsCastr Inc., finding a reasonable likelihood of prevailing on at least one claim. The Board found that claims 1-9 were obvious over combinations of prior art references, specifically demonstrating how known techniques could reduce data latency in live sports content delivery.
patent denied · Aug 22, 2024
Hulu, LLC et al. v.Piranha Media Distribution, LLC
· IPR2024-01253
The PTAB granted Director Review and denied institution of IPR for Hulu against Piranha Media. The denial was based on a prior district court finding that the challenged patent claims were invalid under 35 U.S.C. § 101.
patent instituted · Aug 22, 2024
Hulu, LLC et al. v.Piranha Media Distribution, LLC
· IPR2024-01253
Hulu successfully petitioned against Piranha Media Distribution's patent, arguing that key digital advertising insertion claims are obvious over prior art. The PTAB granted institution, finding a reasonable likelihood of prevailing on the merits for at least one claim.
patent instituted · Aug 22, 2024
Hulu, LLC et al. v.Piranha Media Distribution, LLC
· IPR2024-01252
Hulu successfully petitioned PTAB, leading to institution of its IPR against Piranha Media Distribution. The Board found a reasonable likelihood that claims are unpatentable based on obviousness (103), specifically finding that combining prior art teachings from Wu and Doherty supports the Petitioner's claims in digital advertising insertion.
patent denied · Aug 22, 2024
Hulu, LLC et al. v.Piranha Media Distribution, LLC
· IPR2024-01252
The PTAB denied institution of IPR for Hulu against Piranha, citing a prior district court ruling that the patent claims were invalid under 35 U.S.C. § 101.
patent Final Written Decision · Aug 22, 2024
Apple Inc. v.Proxense, LLC
· IPR2024-01334
The PTAB issued a Final Written Decision finding that the challenged claims were unpatentable over prior art. The Board adopted Petitioner's construction of key terms like 'third party,' concluding that the claimed application is distinct from the trusted authority.
patent final · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01309
The PTAB found that the challenged claims were unpatentable by a preponderance of evidence, rejecting the Patent Owner's arguments against obviousness. The decision centered on whether prior art references (Ellis and Spivey) combined could teach all limitations of the claimed system for live event broadcasting.
patent final · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01308
The PTAB issued a Final Written Decision finding all nine challenged claims unpatentable over combinations of prior art references (Ellis, Spivey, Herzog). The Board relied heavily on the combination of Ellis and Spivey to establish obviousness for Claim 1, particularly regarding low-latency data delivery via uniquely addressable event sockets.
patent final · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01307
The PTAB found that claims 19-25 and 27-30 of the '687 patent were unpatentable over a combination of Ellis and Spivey, based on obviousness (Ground 1). The Board rejected an alternative ground involving Herzog, finding no motivation to combine those references.
patent final · Aug 22, 2024
Genius Sports Ltd. v.SportsCastr Inc.
· IPR2024-01305
The PTAB found claims 1-7 unpatentable over a combination of Ellis, Spivey, and Herzog, concluding that the claimed live video streaming system was obvious to a POSA. The Board specifically held that Spivey's topic queues satisfy the definition of an 'event socket.'
patent · Aug 21, 2024
Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.
· IPR2024-01312
The PTAB has sent a Director Review request to Biofrontera in IPR2024-01312, limiting the petitioner’s response to 15 pages and prohibiting new evidence. The petitioner must respond within five business days.
patent · Aug 21, 2024
Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.
· IPR2024-01312
Sun Pharmaceutical seeks Director Review to overturn a PTAB decision that found several claims of its photodynamic‑therapy device patent unpatentable, arguing the Board mis‑constructed key claim terms and ignored ITC findings.
patent denied · Aug 21, 2024
Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.
· IPR2024-01312
Biofrontera’s petition to overturn the PTAB’s obviousness finding on its photodynamic‑therapy illumination patent was rejected. The Board affirmed that the agreed‑upon claim construction was applied and that the prior‑art combination renders the claims obvious. The Director’s request for review was denied.
patent · Aug 21, 2024
Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.
· IPR2024-01312
Biofrontera has filed an IPR petition challenging Sun Pharmaceutical’s U.S. Patent 11,697,028 covering photodynamic therapy illumination devices, asserting obviousness over Lundahl, Larsen, and Bansal references.
patent instituted · Aug 21, 2024
Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.
· IPR2024-01312
Biofrontera's IPR challenge against Sun Pharmaceutical regarding photodynamic therapy illuminators was instituted by the PTAB. The Board found a reasonable likelihood of prevailing on obviousness grounds over Lundahl and Larsen, focusing on combining prior art elements for flexible device design.
patent final · Aug 21, 2024
Biofrontera Incorporated et al. v.Sun Pharmaceutical Industries, Inc.
· IPR2024-01312
The PTAB found all challenged claims unpatentable by a preponderance of the evidence. The Petitioner successfully argued that combining prior art references (Lundahl and Larsen) rendered the illuminator system obvious to a Person Having Ordinary Skill in the Art (POSITA).
patent · Aug 20, 2024
Geneoscopy, Inc. v.Exact Sciences Corporation
· IPR2024-01330
Geneoscopy challenges Exact Sciences’ colorectal‑cancer fecal‑testing patent (U.S. 11,970,746) in an IPR. The petitioner’s response argues that the patent owner waived any new claim‑construction arguments and that the Board’s obviousness findings are well‑supported. The document urges the Director to deny the request for review.
patent all challenged claims unpatentable · Aug 20, 2024
Geneoscopy, Inc. v.Exact Sciences Corporation
· IPR2024-01330
The PTAB held that all 20 claims of Exact Sciences' 11,634,781 patent are obvious over prior art, rendering them unpatentable. Geneoscopy successfully proved the combination of existing fecal screening methods made the claims non‑inventive.
patent · Aug 20, 2024
Geneoscopy, Inc. v.Exact Sciences Corporation
· IPR2024-01330
Exact Sciences seeks Director Review of a PTAB Final Written Decision that found its at‑home stool‑based colorectal cancer screening patent unpatentable. The request argues the petitioner’s inconsistent claim constructions and reliance on contradictory expert testimony violated Board policy.